Hemodynamic Characteristics of Mechanically Ventilated COVID-19 Patients: A Cohort Analysis
Table 1
Baseline and ICU characteristics.
Baseline
n = 28
Age, years
67 ± 9
Male, n (%)
20 (71)
BMI, kg/m2
30 ± 5
APACHE III score
70 ± 27
Predicted mortality APACHE IV, %
36 ± 24
SOFA score (day 1)
6 ± 3
SOFA score (max)
8 ± 2
Comorbidities, n (%)
Diabetes
4 (14)
Hypertension
13 (46)
Immunocompromised
4 (14)
Medication, n (%)
ACE inhibitor
5 (18)
Angiotensin II receptor blocker
1 (4)
Creatinine (µmol/L)
93 ± 66
ICU period
ICU interventions
Mechanical ventilation, n (%)
28 (100)
Mechanical ventilation, days
17 ± 4
Prone positioning, n (%)
16 (57)
Muscle relaxants, n (%)
26 (93)
Muscle relaxants, days
11 ± 5
Renal replacement therapy, n(%)
3 (11)
Complications, n (%)
Pulmonary embolism
5 (18)
Aspergillosis
3 (11)
Delirium (CAM-ICU confirmed)
27 (95)
ICU survival, n (%)
21 (75)
The data are presented as mean ± SD, unless stated otherwise. BMI: body mass index; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; ACE: angiotensin-converting enzyme; CAM-ICU: Confusion Assessment Method for the ICU [14].
